fluphenazine
Ligand Summary
A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE.
UNII: S79426A41Z
PubChem: 3372
Guide to Pharmacology: 204
ChEMBL: CHEMBL726
DrugCentral: 1212
LyCHI: FQV44DLKAPSW
Target Activities
DRD2
D(2) dopamine receptor
5 Activities
Items per page:
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 8.84 | |||||
Ki | 9.27 | None, None:None:None | ||||
Ki | 8.84 | Bioorg. Med. Chem. Lett., (2009) 19:2:538 | ||||
IC50 | 8.79 | None, None:None:None | ||||
Ki | 9.27 | ANTAGONIST | ||||
HRH1
Histamine H1 receptor
4 Activities
HTR2A
5-hydroxytryptamine receptor 2A
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
7.5 | ||||||
Ki | 8.84 | None, None:None:None | ||||
IC50 | 8.29 | None, None:None:None | ||||
HTR6
5-hydroxytryptamine receptor 6
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
7.8 | ||||||
Ki | 7.62 | None, None:None:None | ||||
IC50 | 7.28 | None, None:None:None | ||||
DRD1
D(1A) dopamine receptor
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
7.7 | ||||||
Ki | 7.96 | None, None:None:None | ||||
IC50 | 7.64 | None, None:None:None | ||||
DRD3
D(3) dopamine receptor
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 9.7 | None, None:None:None | ||||
IC50 | 9.23 | None, None:None:None | ||||
Ki | 8.49 | Bioorg. Med. Chem. Lett., (2009) 19:2:538 | ||||
HTR7
5-hydroxytryptamine receptor 7
2 Activities
DRD5
D(1B) dopamine receptor
2 Activities
HTR2B
5-hydroxytryptamine receptor 2B
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.6 | None, None:None:None | ||||
IC50 | 7.41 | None, None:None:None | ||||
SIGMAR1
Sigma non-opioid intracellular receptor 1
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 8.07 | None, None:None:None | ||||
IC50 | 7.7 | None, None:None:None | ||||
ADRA1D
Alpha-1D adrenergic receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.8 | None, None:None:None | ||||
IC50 | 7.48 | None, None:None:None | ||||
ADRA2B
Alpha-2B adrenergic receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.89 | None, None:None:None | ||||
IC50 | 7.54 | None, None:None:None | ||||
KCNH2
Potassium voltage-gated channel subfamily H member 2
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 5.33 | None, None:None:None | ||||
IC50 | 5.24 | None, None:None:None | ||||
HTR2C
5-hydroxytryptamine receptor 2C
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.46 | None, None:None:None | ||||
IC50 | 7.17 | None, None:None:None | ||||
ADRA2A
Alpha-2A adrenergic receptor
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.1 | None, None:None:None | ||||
SLC6A4
Sodium-dependent serotonin transporter
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 6.1 | None, None:None:None | ||||
CYP1A2
Cytochrome P450 1A2
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AC50 | 6 | None, None:None:None | ||||
ADRA2C
Alpha-2C adrenergic receptor
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.66 | None, None:None:None | ||||
CYP2D6
Cytochrome P450 2D6
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AC50 | 6.2 | None, None:None:None | ||||
KCNK2
Potassium channel subfamily K member 2
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 5.33 | J. Med. Chem., (2016) 59:11:5149 | ||||